Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$160.29 USD

160.29
665,903

-0.78 (-0.48%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $160.26 -0.03 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 246)

Industry: Medical - Hospital

Zacks News

Zacks Equity Research

Select Medical (SEM) Rides on a Diversified Business Profile

Select Medical's (SEM) supremacy in a fragmented market and its affordable healthcare services in each of its business segments bode well for the long haul.

Zacks Equity Research

Tenet Healthcare (THC) Up 126.9% in 6 Months: More Room for Rally?

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to drive its margins, which in turn, might inflate its share price.

Zacks Equity Research

Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care

Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.

Zacks Equity Research

Tenet Healthcare (THC) to Buy 45 Ambulatory Surgery Centers

Tenet Healthcare (THC) to purchase 45 ambulatory surgery centers to aid its USPI ambulatory business, thus bolstering its position as a national musculoskeletal services leader in healthcare.

Zacks Equity Research

Is Tenet Healthcare (THC) a Profitable Stock to Pick Now?

Is Tenet Healthcare (THC) a great pick from the value investor's perspective right now? Read on to know more.

Zacks Equity Research

Why Is Tenet (THC) Up 11.8% Since Last Earnings Report?

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Community Health (CYH) Soars 168.6% YTD: More Room to Run?

Community Health's (CYH) strategic measures along with the surge in telehealth visits are likely to fetch revenues, which in turn, may bump up its share price.

Zacks Equity Research

MEDNAX's (MD) Q3 Earnings Meet Estimates, Revenues Miss

MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.

Zacks Equity Research

Teladoc (TDOC) Q3 Earnings Beat Estimates, Hikes '20 Guidance

Teladoc's (TDOC) third-quarter results reflect robust revenues and solid uptick in patient visits, partially offset by elevated costs.

Zacks Equity Research

Acadia Healthcare's (ACHC) Shares Up on Q3 Earnings Beat

Acadia Healthcare's (ACHC) shares gain on third-quarter earnings beat, which has been driven by higher revenues. However, elevated costs have partially offset the results.

Zacks Equity Research

HCA Healthcare (HCA) Q3 Earnings Miss Estimates, Down Y/Y

HCA Healthcare's (HCA) third-quarter results reflect decline in admissions, partly offset by higher revenues.

Zacks Equity Research

Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y

Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.

Zacks Equity Research

Tenet Healthcare (THC) Tops Q3 Earnings and Revenue Estimates

Tenet (THC) delivered earnings and revenue surprises of 93.94% and 4.76%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's Why You Should Retain Tenet Healthcare (THC) Stock

Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Zacks Equity Research

Analysts Estimate Tenet Healthcare (THC) to Report a Decline in Earnings: What to Look Out for

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

HCA Healthcare (HCA) Announces Preliminary Results for Q3

HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.

Zacks Equity Research

Here's Why You Should Stay Away From HCA Healthcare Now

HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.

Zacks Equity Research

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

Zacks Equity Research

Acadia Healthcare Offers Senior Unsecured Notes for $475M

Acadia Healthcare (ACHC) exhibits sharp business acumen by issuing senior notes to procure funds.

    Sapna Bagaria headshot

    4 Hospital Stocks to Gain from Improving Admissions, Federal Aid

    Federal relief, higher admissions and cost containment are likely to aid the Zacks Medical-Hospital industry. HCA, UHS, CYH and THC are well-positioned to gain from a revival in admissions.

    Zacks Equity Research

    Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

    Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

    Zacks Equity Research

    Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B

    Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.

    Zacks Equity Research

    UHS or THC: Which is a Better-Positioned Stock Right Now?

    Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

    Zacks Equity Research

    What Makes Select Medical (SEM) an Attractive Investment Pick

    Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.

    Zacks Equity Research

    MEDNAX Divests Radiology Business to Focus on Core Operations

    MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.